Kearney, P. M. et al. Global burden of hypertension: analysis of worldwide data. Lancet 365, 217-223

Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA.
The Lancet (Impact Factor: 45.22). 01/2005; 365(9455):217-23. DOI: 10.1016/S0140-6736(05)17741-1
Source: PubMed

ABSTRACT Reliable information about the prevalence of hypertension in different world regions is essential to the development of national and international health policies for prevention and control of this condition. We aimed to pool data from different regions of the world to estimate the overall prevalence and absolute burden of hypertension in 2000, and to estimate the global burden in 2025.
We searched the published literature from Jan 1, 1980, to Dec 31, 2002, using MEDLINE, supplemented by a manual search of bibliographies of retrieved articles. We included studies that reported sex-specific and age-specific prevalence of hypertension in representative population samples. All data were obtained independently by two investigators with a standardised protocol and data-collection form.
Overall, 26.4% (95% CI 26.0-26.8%) of the adult population in 2000 had hypertension (26.6% of men [26.0-27.2%] and 26.1% of women [25.5-26.6%]), and 29.2% (28.8-29.7%) were projected to have this condition by 2025 (29.0% of men [28.6-29.4%] and 29.5% of women [29.1-29.9%]). The estimated total number of adults with hypertension in 2000 was 972 million (957-987 million); 333 million (329-336 million) in economically developed countries and 639 million (625-654 million) in economically developing countries. The number of adults with hypertension in 2025 was predicted to increase by about 60% to a total of 1.56 billion (1.54-1.58 billion).
Hypertension is an important public-health challenge worldwide. Prevention, detection, treatment, and control of this condition should receive high priority.

  • Source
    • "Hypertension remains a global public health challenge. An estimated 26% of all adults worldwide have hypertension (Kearney et al., 2005). Hypertension is the primary cause of cardiovascular diseases (CVD) and 13% of deaths are associated with CVD, 62% of strokes and 49% of ischemic heart disease events are attributable to raised blood pressure (WHO, 2002, 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: To examine if employees with higher nutrition knowledge have better diet quality and lower prevalence of hypertension.
    12/2015; 2:105-113. DOI:10.1016/j.pmedr.2014.11.008
  • Source
    • "Hypertension (HTN) is the leading modifiable risk factor for mortality worldwide [1], accounting for more than 40% of the deaths caused by cardiovascular diseases (CVDs), renal diseases and type 2 diabetes mellitus [2]. It is estimated that 29% of world population, or 1.56 billion people, will have HTN by 2025, with approximately three-fourths of them living in developing countries [3]. In Brazil, the surveillance of Protective and Risk Factors for Chronic Diseases by Telephone Survey (VIGITEL) [4], conducted on a probability sample of telephone households drawn from telephone directories of the capitals in the country, and involving 52,929 individuals, showed a prevalence of HTN about 26% (95% CI 23.2 -28.0) (22.9% of men [95% CI 19.3% -26.6%] and 27.8% of women [95% CI 24.7% -30.9%]). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hypertension (HTN) is the risk factor that most contributes to mortality rates in the world, followed by physical inactivity and obesity. Despite the influence of genetic factors on the genesis of HTN, blood pressure levels are strongly influenced by environmental factors such as physical inactivity and overweight, characterizing it as a polygenic disease. Genetic components and environmental factors such as physical exercise may modulate the phenotype of individuals predis-posed to medical conditions such as HTN, independently of modifiable factors such as increased levels of adiposity; however, studies have shown that polymorphic forms detected in genes involved in the mechanisms of blood pressure regulation and also related to body fat modulation may interact with physical activity levels and HTN. The aim of this article is to review the interactions between polymorphisms in ADRB2, ADRB3, BDKRB2 and MTNR1B genes, physical activity and blood pressure.
    Open Journal of Endocrine and Metabolic Diseases 08/2015; 5(07):88-97. DOI:10.4236/ojemd.2015.57012
  • Source
    • "Hypertension is a worldwide epidemic causing 7.1 million premature deaths each year and accounting for 13% of all deaths globally [1]. Kearney et al. [2] reported that overall prevalence of hypertension in 2000 was estimated to be 26.4% of the world population and predicted that the burden of hypertension would increase by 60% to approximately 1.56 billion in the year 2025. Also, hypertension results in an economic burden of $47.5 billion annually in direct medical expenses and $3.5 billion each year in lost productivity [3]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Controlling hypertension is essential in cardiovascular disease. Poor medication adherence is associated with poor disease outcomes, waste of healthcare resources, and contributes to reduced blood pressure control. This study evaluates treatment adherence to antihypertensive therapy in Lebanese hypertensive patients by estimating the proportion of adherent hypertensive patients using a validated tool and investigates what factors predict this behavior. A questionnaire-based cross-sectional study was conducted on a random sample of 210 hypertensive outpatients selected from clinics located in tertiary-care hospitals and from private cardiology clinics located in Beirut. Adherence level was measured using a validated 8-item Modified Morisky Medication Adherence Scale (MMMAS). Among 210 patients, 50.5% showed high adherence, 27.1% medium adherence, and 22.4% low adherence to medication. Mean MMMAS score was 6.59±2.0. In bivariate analyses, having controlled blood pressure (p=0.003) and taking a combination drug (p=0.023) were predictors of high adherence. Forgetfulness (p<0.01), complicated drug regimen (p=0.001), and side effects (p=0.006) were predictors of low adherence after multiple liner regression. Logistic regression results showed that calcium channel blockers (p=0.030) were associated with increased adherence levels. In conclusion, developing multidisciplinary intervention programs to address the factors identified, in addition to educational strategies targeting healthcare providers, are necessary to enhance patient adherence. Copyright © 2015. Published by Elsevier Ltd.
    07/2015; DOI:10.1016/j.jegh.2015.07.002
Show more